Snu Rdb Foundation

Korea Institute of Science and Technology

Dongguk University Industry-academic Cooperation Foundation

Jeong Yeon Kim

Ji Hye Kim

Kwang Meyung Kim

Cheol Hee Ahn

Dong Eog Kim

Sung Mo Park

Suk Won Lee

In Cheol Sun

Beom Jong Song

Bo Bae An

Sung Kyung Park

Jun Uk Lee

Suk Woo Choi

In Gie Hong

The present invention relates to a CT contrast agent for detecting a thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles. The CT contrast agent for detecting a thrombus according to an embodiment of the present invention may allow rapid and repeated acquisition of CT image information related to the size and location of a thrombus in cardio-cerebral vascular thrombosis, and also enables the imaging monitoring of cerebral thrombus.

CT contrast medium for detecting thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles

The present disclosure relates to a composition for treating anxiety disorder, particularly to a pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder such as post traumatic stress disorder or phobia. In accordance with the present disclosure, N-acetyl-L-cysteine can block the renewal of fear memories for a sustained period of time when it was administered during or after an exposure therapy to treat post traumatic stress disorder or phobia.

Pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder

Growing community of inventors

Gyeonggi-do, South Korea

Jeong Yeon Kim